239 related articles for article (PubMed ID: 24421077)
21. Survival of patients with head and neck cancer treated with definitive radiotherapy and concurrent cisplatin or concurrent cetuximab: A Surveillance, Epidemiology, and End Results-Medicare analysis.
Xiang M; Holsinger FC; Colevas AD; Chen MM; Le QT; Beadle BM
Cancer; 2018 Dec; 124(23):4486-4494. PubMed ID: 30332498
[TBL] [Abstract][Full Text] [Related]
22. Clinical Outcomes of Several IMRT Techniques for Patients With Head and Neck Cancer: A Propensity Score-Weighted Analysis.
Bibault JE; Dussart S; Pommier P; Morelle M; Huguet M; Boisselier P; Coche-Dequeant B; Alfonsi M; Bardet E; Rives M; Calugaru V; Chajon E; Noel G; Mecellem H; Servagi Vernat S; Perrier L; Giraud P
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):929-937. PubMed ID: 28864403
[TBL] [Abstract][Full Text] [Related]
23. Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy.
Chen AM; Daly ME; Farwell DG; Vazquez E; Courquin J; Lau DH; Purdy JA
JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):129-33. PubMed ID: 24337483
[TBL] [Abstract][Full Text] [Related]
24. Toxicity and efficacy of cetuximab associated with several modalities of IMRT for locally advanced head and neck cancer.
Bibault JE; Morelle M; Perrier L; Pommier P; Boisselier P; Coche-Dequéant B; Gallocher O; Alfonsi M; Bardet É; Rives M; Calugaru V; Chajon E; Noël G; Mecellem H; Pérol D; Dussart S; Giraud P
Cancer Radiother; 2016 Jul; 20(5):357-61. PubMed ID: 27345843
[TBL] [Abstract][Full Text] [Related]
25. Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure.
Frank SJ; Rosenthal DI; Petsuksiri J; Ang KK; Morrison WH; Weber RS; Glisson BS; Chao KS; Schwartz DL; Chronowski GM; El-Naggar AK; Garden AS
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1005-10. PubMed ID: 20207504
[TBL] [Abstract][Full Text] [Related]
26. Hospital volume is associated with survival but not multimodality therapy in Medicare patients with advanced head and neck cancer.
Sharma A; Schwartz SM; Méndez E
Cancer; 2013 May; 119(10):1845-52. PubMed ID: 23456789
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of intensity-modulated radiotherapy versus conventional radiotherapy for hypopharyngeal cancer.
Mok G; Gauthier I; Jiang H; Huang SH; Chan K; Witterick IJ; O'Sullivan B; Waldron JN; Bayley AJ; Cho BC; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; Ringash J
Head Neck; 2015 May; 37(5):655-61. PubMed ID: 24590756
[TBL] [Abstract][Full Text] [Related]
28. Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.
Villeneuve H; Després P; Fortin B; Filion E; Donath D; Soulières D; Guertin L; Ayad T; Christopoulos A; Nguyen-Tan PF
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1866-71. PubMed ID: 21497452
[TBL] [Abstract][Full Text] [Related]
29. Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinoma.
Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
PLoS One; 2018; 13(7):e0200137. PubMed ID: 29979726
[TBL] [Abstract][Full Text] [Related]
30. Comparing Risk for Second Primary Cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for Prostate Cancer, 2002-2015.
Pithadia KJ; Advani PG; Citrin DE; Bekelman JE; Withrow DR; Berrington de Gonzalez A; Morton LM; Schonfeld SJ
JAMA Oncol; 2023 Aug; 9(8):1119-1123. PubMed ID: 37289449
[TBL] [Abstract][Full Text] [Related]
31. Evaluating Intensity-Modulated Radiation Therapy in Locally Advanced Non-Small-Cell Lung Cancer: Results From the National Cancer Data Base.
Jegadeesh N; Liu Y; Gillespie T; Fernandez F; Ramalingam S; Mikell J; Lipscomb J; Curran WJ; Higgins KA
Clin Lung Cancer; 2016 Sep; 17(5):398-405. PubMed ID: 26936682
[TBL] [Abstract][Full Text] [Related]
32. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
33. Long term results of postoperative Intensity-Modulated Radiation Therapy (IMRT) in the treatment of Squamous Cell Carcinoma (SCC) located in the oropharynx or oral cavity.
Hoffmann M; Saleh-Ebrahimi L; Zwicker F; Haering P; Schwahofer A; Debus J; Huber PE; Roeder F
Radiat Oncol; 2015 Dec; 10():251. PubMed ID: 26637471
[TBL] [Abstract][Full Text] [Related]
34. Small Cell and Squamous Cell Carcinomas of the Head and Neck: Comparing Incidence and Survival Trends Based on Surveillance, Epidemiology, and End Results (SEER) Data.
Bean MB; Liu Y; Jiang R; Steuer CE; Patel M; McDonald MW; Higgins KA; Beitler JJ; Shin DM; Saba NF
Oncologist; 2019 Dec; 24(12):1562-1569. PubMed ID: 31391295
[TBL] [Abstract][Full Text] [Related]
35. Outcomes between intensity-modulated radiation therapy versus 3D-conformal in early stage glottic cancer.
Amini A; Morgan R; Meyer E; Fakhoury K; Ladbury C; Bickett T; McDermott JD; Stokes W; Karam SD
Head Neck; 2021 Nov; 43(11):3393-3403. PubMed ID: 34382714
[TBL] [Abstract][Full Text] [Related]
36. Randomized controlled study comparing simultaneous modulated accelerated radiotherapy versus simultaneous integrated boost intensity modulated radiotherapy in the treatment of locally advanced head and neck cancer.
Tandon S; Gairola M; Ahlawat P; Rawat S; Aggarwal A; Sharma K; Tiwari S; Karimi AM; Muttagi V; Sachdeva N; Bhushan M
J Egypt Natl Canc Inst; 2018 Sep; 30(3):107-115. PubMed ID: 29960876
[TBL] [Abstract][Full Text] [Related]
37. IMRT-based treatment of unknown primary malignancy of the head and neck: Outcomes and improved toxicity with decreased mucosal dose and larynx sparing.
LaVigne AW; Margalit DN; Rawal B; Puzanov M; Annino DJ; Goguen LA; Sher DJ; Schoenfeld JD; Chau NG; Lorch JH; Rabinowits G; Haddad RI; Tishler RB
Head Neck; 2019 Apr; 41(4):959-966. PubMed ID: 30620435
[TBL] [Abstract][Full Text] [Related]
38. Intensity-modulated radiotherapy is associated with improved global quality of life among long-term survivors of head-and-neck cancer.
Chen AM; Farwell DG; Luu Q; Vazquez EG; Lau DH; Purdy JA
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):170-5. PubMed ID: 22300572
[TBL] [Abstract][Full Text] [Related]
39. Hypothyroidism after 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for head and neck cancers: prospective data from 2 randomized controlled trials.
Murthy V; Narang K; Ghosh-Laskar S; Gupta T; Budrukkar A; Agrawal JP
Head Neck; 2014 Nov; 36(11):1573-80. PubMed ID: 23996654
[TBL] [Abstract][Full Text] [Related]
40. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques.
Longobardi B; De Martin E; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Calandrino R
Radiother Oncol; 2005 Nov; 77(2):148-56. PubMed ID: 16260056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
